147 related articles for article (PubMed ID: 32543327)
1. Predictors of severe adverse outcomes in febrile neutropenia of pediatric oncology patients at a single institute in Thailand.
Suttitossatam I; Satayasai W; Sinlapamongkolkul P; Pusongchai T; Sritipsukho P; Surapolchai P
Pediatr Hematol Oncol; 2020 Oct; 37(7):561-572. PubMed ID: 32543327
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients.
Bothra M; Seth R; Kapil A; Dwivedi SN; Bhatnagar S; Xess I
Indian J Pediatr; 2013 Apr; 80(4):297-302. PubMed ID: 23255077
[TBL] [Abstract][Full Text] [Related]
3. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
5. Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
Bennett CL; Stinson TJ; Laver JH; Bishop MR; Godwin JE; Tallman MS
Leuk Lymphoma; 2000 Mar; 37(1-2):65-70. PubMed ID: 10721770
[TBL] [Abstract][Full Text] [Related]
6. Outcome of febrile neutropenic patients on granulocyte colony stimulating factor in a tertiary care hospital.
Osmani AH; Ansari TZ; Masood N; Ahmed B
Asian Pac J Cancer Prev; 2012; 13(6):2523-6. PubMed ID: 22938399
[TBL] [Abstract][Full Text] [Related]
7. Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.
Villanueva MA; August KJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1829-33. PubMed ID: 27196265
[TBL] [Abstract][Full Text] [Related]
8. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience.
Li MJ; Chang HH; Yang YL; Lu MY; Shao PL; Fu CM; Chou AK; Liu YL; Lin KH; Huang LM; Lin DT; Jou ST
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371256
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of febrile neutropenia in patients with hematological disease-a prospective multicentre survey in China].
Yan CH; Xu T; Zheng XY; Sun J; Duan XL; Gu JL; Zhao CL; Zhu J; Wu YH; Wu DP; Hu JD; Huang H; Jiang M; Li J; Hou M; Wang C; Shao ZH; Liu T; Hu Y; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):177-82. PubMed ID: 27033752
[TBL] [Abstract][Full Text] [Related]
10. Role of granulocyte colony-stimulating factor as adjunct therapy for septicemia in children with acute leukemia.
Liang DC; Chen SH; Lean SF
Am J Hematol; 1995 Feb; 48(2):76-81. PubMed ID: 7531394
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia.
Ohno R
Leuk Res; 1998 Dec; 22(12):1143-54. PubMed ID: 9922078
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.
Esbenshade AJ; Pentima MC; Zhao Z; Shintani A; Esbenshade JC; Simpson ME; Montgomery KC; Lindell RB; Lee H; Wallace A; Garcia KL; Moons KG; Friedman DL
Pediatr Blood Cancer; 2015 Feb; 62(2):262-268. PubMed ID: 25327666
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Microbiologically-documented Infections, Mortality and Prolonged Hospital Stay in Children with Febrile Neutropenia.
Das A; Trehan A; Bansal D
Indian Pediatr; 2018 Oct; 55(10):859-864. PubMed ID: 29941699
[TBL] [Abstract][Full Text] [Related]
14. Bacteremia in nonneutropenic pediatric oncology patients with central venous catheters in the ED.
Moskalewicz RL; Isenalumhe LL; Luu C; Wee CP; Nager AL
Am J Emerg Med; 2017 Jan; 35(1):20-24. PubMed ID: 27765482
[TBL] [Abstract][Full Text] [Related]
15. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
[TBL] [Abstract][Full Text] [Related]
16. Febrile neutropenic infection occurred in cancer patients undergoing autologous peripheral blood stem cell transplantation.
Zhang WX; Zhao QY; Huang HQ
Transplant Proc; 2015 Mar; 47(2):523-7. PubMed ID: 25769601
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
18. Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors.
Laali E; Fazli J; Sadighi S; Mohammadi M; Gholami K; Jahangard-Rafsanjani Z
J Oncol Pharm Pract; 2020 Mar; 26(2):428-433. PubMed ID: 31615347
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
20. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
